DeepMed Research

University of Oxford

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private

Established: 1096-01-01

Employees: 10K

Market Cap: -

Website: http://www.ox.ac.uk

Clinical Trials

A Study of the Plasmodium Falciparum Malaria Vaccine Candidate Pfs48/45 in Matrix-M Adjuvant in the UK

Early Phase 1

Terminated

Conditions: Malaria
Plasmodium Falciparum

Interventions: Biological: Pfs48/45 in Matrix-M

First Posted Date: 2022-06-02

Last Posted Date: 2025-03-28

Lead Sponsor: University of Oxford

Target Recruit Count: 17

Registration Number: NCT05400746

Locations: 🇬🇧
CCVTM, Churchill Hospital, University of Oxford, Oxford, United Kingdom

Functional and Ultrasound Guided Resection of Glioblastoma

Not Applicable

Recruiting

Conditions: Glioma Glioblastoma Multiforme

Interventions: Other: Additional pre- and intra-operative imaging
Other: Standard of Care

First Posted Date: 2022-06-01

Last Posted Date: 2022-06-01

Lead Sponsor: University of Oxford

Target Recruit Count: 357

Registration Number: NCT05399524

Locations: 🇬🇧
Addenbrookes Hospital, Cambridge University NHSFT, Cambridge, United Kingdom
🇬🇧
University Hospital, Coventry, Coventry, United Kingdom
🇬🇧
Queen's Medical Centre, Nottingham University Hospitals NHST, Nottingham, United Kingdom

and more 21 locations

Rural South and Southeast Asia Household Health Survey

Completed

Conditions: Infections
Risk Factors
Health Status
Noncommunicable Disease

First Posted Date: 2022-05-25

Last Posted Date: 2024-02-28

Lead Sponsor: University of Oxford

Target Recruit Count: 4747

Registration Number: NCT05389540

Locations: 🇧🇩
BangladeshBuilding Resources Across Communities (BRAC), Dhaka, Bangladesh
🇰🇭
Cambodia Action for Health Development (AHEAD), Battambang, Cambodia
🇲🇲
Medical Action Myanmar (MAM), Yangon, Myanmar

and more 1 locations

Assessment of Safety and Immunogenicity of R21/Matrix-M™ in African Children Living With HIV

Phase 1

Active, not recruiting

Conditions: Malaria

Interventions: Biological: R21/Matrix-M™

First Posted Date: 2022-05-23

Last Posted Date: 2024-10-22

Lead Sponsor: University of Oxford

Target Recruit Count: 120

Registration Number: NCT05385510

Locations: 🇺🇬
MRC/UVRI & LSHTM Uganda Research Unit, Entebbe, Uganda

A Phase Ia Clinical Trial to Assess the Safety and Immunogenicity of the Blood-stage Malaria Candidate Vaccines RH5.1 in Matrix-M and R78C in Matrix-M in Healthy UK Adults

Early Phase 1

Active, not recruiting

Conditions: Malaria, Falciparum

Interventions: Biological: Matrix M with R78C and/or RH5.1

First Posted Date: 2022-05-23

Last Posted Date: 2025-04-01

Lead Sponsor: University of Oxford

Target Recruit Count: 36

Registration Number: NCT05385471

Locations: 🇬🇧
CCVTM, University of Oxford, Churchill Hospital, Oxford, United Kingdom

Iron and Immune Response to Vaccine (IRONMUM)

Not Applicable

Conditions: Pregnancy Related

Interventions: Dietary Supplement: Sangobion and Thiamine Hydrochloride
Dietary Supplement: Sangobion, Thiamine hydrochloride and Vitamin B12

First Posted Date: 2022-05-23

Last Posted Date: 2025-02-21

Lead Sponsor: University of Oxford

Target Recruit Count: 150

Registration Number: NCT05385042

Locations: 🇹🇭
Shoklo Malaria Research Unit (SMRU), Mae Sot, Tak, Thailand

VIM DBS Respiratory Modulation: N-of-1 Trial

Withdrawn

Conditions: Essential Tremor
Dystonic Tremor

Interventions: Procedure: VIM DBS

First Posted Date: 2022-05-19

Last Posted Date: 2022-05-19

Lead Sponsor: University of Oxford

Registration Number: NCT05381688

A Safety, Immunogenicity and Efficacy Study of PvRII/Matrix-M in Healthy Thai Adults Living in Thailand ( MIST3 )

Phase 2

Not yet recruiting

Conditions: Plasmodium Vivax Infection
Malaria Vaccine

Interventions: Biological: Malaria Vaccine
Biological: HBV vaccine

First Posted Date: 2022-05-18

Last Posted Date: 2025-03-27

Lead Sponsor: University of Oxford

Target Recruit Count: 36

Registration Number: NCT05380388

Locations: 🇹🇭
Faculty of Tropical Medicine, Bangkok, Thailand

SCOOT: Sample Collection for DART

Recruiting

Conditions: Lung Cancer

First Posted Date: 2022-05-10

Last Posted Date: 2025-04-27

Lead Sponsor: University of Oxford

Target Recruit Count: 5000

Registration Number: NCT05368298

Locations: 🇬🇧
Lung Health Check Centre: Royal Sussex, Brighton, United Kingdom
🇬🇧
Lung Health Check Centre: Gateshead, Gateshead, United Kingdom
🇬🇧
Lung Health Check Centre: Stoke, Stoke, United Kingdom

and more 7 locations

Serotonin-receptor Agonism in Reward Processing

Phase 2

Completed

Conditions: Anhedonia

Interventions: Drug: Placebo comparator
Drug: Buspirone 20mg

First Posted Date: 2022-05-03

Last Posted Date: 2023-05-11

Lead Sponsor: University of Oxford

Target Recruit Count: 63

Registration Number: NCT05357547

Locations: 🇬🇧
Neurosciences building, Department of Psychiatry, Warneford hospital, Oxford, Oxfordshire, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy